Indication

Exposure to plutonium radiation

**Exposure to plutonium radiation** refers to internal contamination or external contact with radioactive transuranic isotopes of plutonium (most commonly plutonium-238, plutonium-239, or plutonium-240), typically sustained via inhalation of particulate aerosols, direct wound contamination, or accidental ingestion. Read more about Exposure to plutonium radiation

6 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Exposure to plutonium radiation therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Exposure to plutonium radiation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Exposure to plutonium radiation.

**Exposure to plutonium radiation** refers to internal contamination or external contact with radioactive transuranic isotopes of plutonium (most commonly plutonium-238, plutonium-239, or plutonium-240), typically sustained via inhalation of particulate aerosols, direct wound contamination, or accidental ingestion.

While intact stratum corneum largely shields against external alpha particles, internally deposited plutonium poses severe radiotoxic and chemical hazards, preferentially distributing through the systemic circulation to accumulate chronically in the lungs, skeleton, and liver.

Pathophysiologically, the continuous localized emission of high-energy, high-linear-energy-transfer (LET) alpha radiation induces double-strand DNA damage, cell death, and progressive tissue fibrosis.

This process leads to long-term deterministic and stochastic clinical sequelae, notably pulmonary pneumonitis, osteosarcoma, hepatic injury, and lung carcinoma.

Personalize your experience

Follow Exposure to plutonium radiation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it